ReviewAmerican journal of cancer research2021

Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy.

Parham Jabbarzadeh Kaboli et al.PubMed ↗Full text ↗

No numbers read from the abstract.